Skip to main content
Premium Trial:

Request an Annual Quote

Cellomics Acquires UK Software Firm Momentum Healthcare

NEW YORK, July 12 - Cellomics, the Pittsburgh, PA-based maker of integrated informatics and cell-screening technologies, has acquired Momentum Healthcare, a developer of drug discovery software, the company said Thursday.

Terms of the deal, which was formalized today but has been under negotiation for some time, were not disclosed and a company official declined to comment immediately.

Ian Shaw, the CEO of Momentum, has relocated from the company's headquarters in Southampton and Cardiff, UK, to Pittsburgh to take the position as vice president of therapeutic discovery for Cellomics. Mark Collins of Momentum has also moved to the US to become Cellomics' senior director of pharmaceutical informatics.   

This merger comes eight months after Cellomics postponed its initial public offering.


The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.